期刊
INFLAMMOPHARMACOLOGY
卷 23, 期 4, 页码 131-150出版社
SPRINGER BASEL AG
DOI: 10.1007/s10787-015-0241-4
关键词
Rheumatoid arthritis; Animal model; Refinement; Three Rs; Ethical review; Humane endpoint; Welfare assessment; Experimental design; Autoimmune disease
资金
- Kennedy Trust for Rheumatology Research
- European Union (FP7 Project PRIAT) [305309]
- Versus Arthritis [19788] Funding Source: researchfish
Rheumatoid arthritis (RA) is a painful, chronic disorder and there is currently an unmet need for effective therapies that will benefit a wide range of patients. The research and development process for therapies and treatments currently involves in vivo studies, which have the potential to cause discomfort, pain or distress. This Working Group report focuses on identifying causes of suffering within commonly used mouse and rat 'models' of RA, describing practical refinements to help reduce suffering and improve welfare without compromising the scientific objectives. The report also discusses other, relevant topics including identifying and minimising sources of variation within in vivo RA studies, the potential to provide pain relief including analgesia, welfare assessment, humane endpoints, reporting standards and the potential to replace animals in RA research.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据